267 related articles for article (PubMed ID: 3360052)
1. Pharmacokinetics and bioavailability of reduced and oxidized N-acetylcysteine.
Olsson B; Johansson M; Gabrielsson J; Bolme P
Eur J Clin Pharmacol; 1988; 34(1):77-82. PubMed ID: 3360052
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics and bioavailability of oral acetylcysteine in healthy volunteers.
De Caro L; Ghizzi A; Costa R; Longo A; Ventresca GP; Lodola E
Arzneimittelforschung; 1989 Mar; 39(3):382-6. PubMed ID: 2757663
[TBL] [Abstract][Full Text] [Related]
3. Bioavailability of suckable tablets of oral N-acetylcysteine in man.
De Bernardi di Valserra M; Mautone G; Barindelli E; Lualdi P; Feletti F; Galmozzi MR
Eur J Clin Pharmacol; 1989; 37(4):419-21. PubMed ID: 2598977
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of N-acetylcysteine after oral and intravenous administration to healthy cats.
Buur JL; Diniz PP; Roderick KV; KuKanich B; Tegzes JH
Am J Vet Res; 2013 Feb; 74(2):290-3. PubMed ID: 23363356
[TBL] [Abstract][Full Text] [Related]
5. Intravenous Administration of Stable-Labeled N-Acetylcysteine Demonstrates an Indirect Mechanism for Boosting Glutathione and Improving Redox Status.
Zhou J; Coles LD; Kartha RV; Nash N; Mishra U; Lund TC; Cloyd JC
J Pharm Sci; 2015 Aug; 104(8):2619-26. PubMed ID: 26052837
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics and bioavailability of intravenous and oral chlordesmethyldiazepam in humans.
Bareggi SR; Truci G; Leva S; Zecca L; Pirola R; Smirne S
Eur J Clin Pharmacol; 1988; 34(1):109-12. PubMed ID: 2896126
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of N-acetylcysteine are altered in patients with chronic liver disease.
Jones AL; Jarvie DR; Simpson D; Hayes PC; Prescott LF
Aliment Pharmacol Ther; 1997 Aug; 11(4):787-91. PubMed ID: 9305490
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of N-acetylcysteine in man.
Borgström L; Kågedal B; Paulsen O
Eur J Clin Pharmacol; 1986; 31(2):217-22. PubMed ID: 3803419
[TBL] [Abstract][Full Text] [Related]
9. Multiple-dose pharmacokinetics and pharmacodynamics of N-acetylcysteine in patients with end-stage renal disease.
Nolin TD; Ouseph R; Himmelfarb J; McMenamin ME; Ward RA
Clin J Am Soc Nephrol; 2010 Sep; 5(9):1588-94. PubMed ID: 20538838
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics and absolute bioavailability of colchicine after i.v. and oral administration in healthy human volunteers and elderly subjects.
Rochdi M; Sabouraud A; Girre C; Venet R; Scherrmann JM
Eur J Clin Pharmacol; 1994; 46(4):351-4. PubMed ID: 7957521
[TBL] [Abstract][Full Text] [Related]
11. Human pharmacokinetics of erythromycin propionate-N-acetylcysteinate: comparative evaluation with erythromycin stearate and N-acetylcysteine.
De Bernardi M; Feletti F; Gazzani G; Fregnan GB
Int J Clin Pharmacol Ther Toxicol; 1988 Sep; 26(9):444-7. PubMed ID: 3198299
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of tramadol and bioavailability of enteral tramadol formulations. 2nd communication: drops with ethanol.
Lintz W; Barth H; Becker R; Frankus E; Schmidt-Böthelt E
Arzneimittelforschung; 1998 May; 48(5):436-45. PubMed ID: 9638309
[TBL] [Abstract][Full Text] [Related]
13. The pharmacokinetics of intravenous and oral sulpiride in healthy human subjects.
Wiesel FA; Alfredsson G; Ehrnebo M; Sedvall G
Eur J Clin Pharmacol; 1980 May; 17(5):385-91. PubMed ID: 7418717
[TBL] [Abstract][Full Text] [Related]
14. Dose dependent pharmacokinetics of N-acetylcysteine after oral dosing to man.
Borgström L; Kågedal B
Biopharm Drug Dispos; 1990 Mar; 11(2):131-6. PubMed ID: 2328298
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics and bioavailability of benperidol in schizophrenic patients after intravenous and two different kinds of oral application.
Seiler W; Wetzel H; Hillert A; Schöllnhammer G; Langer M; Barlage U; Hiemke C
Psychopharmacology (Berl); 1994 Dec; 116(4):457-63. PubMed ID: 7701049
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of intravenous N-acetylcysteine in men at rest and during exercise.
Brown M; Bjorksten A; Medved I; McKenna M
Eur J Clin Pharmacol; 2004 Dec; 60(10):717-23. PubMed ID: 15619135
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of N-acetylcysteine following repeated intravenous infusion in haemodialysed patients.
Soldini D; Zwahlen H; Gabutti L; Marzo A; Marone C
Eur J Clin Pharmacol; 2005 Feb; 60(12):859-64. PubMed ID: 15657783
[TBL] [Abstract][Full Text] [Related]
18. Bioavailability and pharmacokinetics of oxazepam.
Sonne J; Loft S; Døssing M; Vollmer-Larsen A; Olesen KL; Victor M; Andreasen F; Andreasen PB
Eur J Clin Pharmacol; 1988; 35(4):385-9. PubMed ID: 3197746
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics and bioavailability of midazolam in man.
Heizmann P; Eckert M; Ziegler WH
Br J Clin Pharmacol; 1983; 16 Suppl 1(Suppl 1):43S-49S. PubMed ID: 6138080
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of brotizolam in healthy subjects following intravenous and oral administration.
Jochemsen R; Wesselman JG; Hermans J; van Boxtel CJ; Breimer DD
Br J Clin Pharmacol; 1983; 16 Suppl 2(Suppl 2):285S-290S. PubMed ID: 6661374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
